Journal
JOURNAL OF CONTROLLED RELEASE
Volume 162, Issue 2, Pages 464-473Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2012.07.034
Keywords
Mesenchymal stem cells; Brain diseases; Migration; Trophic factors
Funding
- National Natural Science Foundation of China [30873173, 81001410]
- Fundamental Research Funds for the Central Universities, China
- China-Japan Scientific Cooperation Program [81011140077]
- NSFC, China
- JSPS, Japan
Ask authors/readers for more resources
Transplantation of mesenchymal stem cells (MSCs) into the injured brain may provide therapeutic benefits. Several models of brain diseases have been examined, including that of ischemic stroke, neurodegenerative diseases and brain tumors. MSCs transplanted into the brain have been demonstrated to promote functional recovery by producing trophic factors that induce survival and regeneration of host neurons. Therapies will capitalize on the innate trophic support from MSCs or on augmented growth factor support, using genetically engineered MSCs as the delivery vehicles. Genetically engineered and surface modified methods are supposed to enhance the migration of MSCs toward brain lesions. The current data in support of applying MSC-based cellular therapies to the treatment of brain disorders are discussed. (C) 2012 Elsevier B. V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available